Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126096761 | 12609676 | 1 | I | 201412 | 20160728 | 20160801 | 20160801 | EXP | PHHY2016BR104613 | NOVARTIS | 86.17 | YR | M | Y | 0.00000 | 20160801 | CN | COUNTRY NOT SPECIFIED | BR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126096761 | 12609676 | 1 | PS | EXELON PATCH | RIVASTIGMINE | 1 | Transdermal | PATCH 5 (CM2) | 22083 | 4.6 | MG | TRANS-THERAPEUTIC-SYSTEM | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126096761 | 12609676 | 1 | Dementia Alzheimer's type |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126096761 | 12609676 | DE |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126096761 | 12609676 | Death |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126096761 | 12609676 | 1 | 2014 | 0 |